Multicenter Evaluation of BioFire FilmArray Respiratory Panel 2 for Detection of Viruses and Bacteria in Nasopharyngeal Swab Samples

Amy L Leber, Kathy Everhart, Judy A Daly, Aubrey Hopper, Amanda Harrington, Paul Schreckenberger, Kathleen McKinley, Matthew Jones, Kristen Holmberg, Bart Kensinger, Amy L Leber, Kathy Everhart, Judy A Daly, Aubrey Hopper, Amanda Harrington, Paul Schreckenberger, Kathleen McKinley, Matthew Jones, Kristen Holmberg, Bart Kensinger

Abstract

The FilmArray Respiratory Panel 2 (RP2) is a multiplex in vitro diagnostic test for the simultaneous and rapid (∼45-min) detection of 22 pathogens directly from nasopharyngeal swab (NPS) samples. It contains updated (and in some instances redesigned) assays that improve upon the FilmArray Respiratory Panel (RP; version 1.7), with a faster run time. The organisms identified are adenovirus, coronavirus 229E, coronavirus HKU1, coronavirus NL63, coronavirus OC43, human metapneumovirus, human rhinovirus/enterovirus, influenza virus A, influenza virus A H1, influenza virus A H1-2009, influenza virus A H3, influenza virus B, parainfluenza virus 1, parainfluenza virus 2, parainfluenza virus 3, parainfluenza virus 4, respiratory syncytial virus, Bordetella pertussis, Chlamydia pneumoniae, and Mycoplasma pneumoniae Two new targets are included in the FilmArray RP2: Middle East respiratory syndrome coronavirus and Bordetella parapertussis This study provides data from a multicenter evaluation of 1,612 prospectively collected NPS samples, with performance compared to that of the FilmArray RP or PCR and sequencing. The overall percent agreement between the FilmArray RP2 and the comparator testing was 99.2%. The RP2 demonstrated a positive percent agreement of 91.7% or greater for detection of all but three analytes: coronavirus OC43, B. parapertussis, and B. pertussis The FilmArray RP2 also demonstrated a negative percent agreement of ≥93.8% for all analytes. Of note, the adenovirus assay detects all genotypes, with a demonstrated increase in sensitivity. The FilmArray RP2 represents a significant improvement over the FilmArray RP, with a substantially shorter run time that could aid in the diagnosis of respiratory infections in a variety of clinical scenarios.

Keywords: PCR; respiratory pathogens; syndromic testing.

Copyright © 2018 Leber et al.

References

    1. Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, Bridges CB. 2007. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 25:5086–5096. doi:10.1016/j.vaccine.2007.03.046.
    1. Fendrick AM, Monto AS, Nightengale B, Sarnes M. 2003. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med 163:487–494. doi:10.1001/archinte.163.4.487.
    1. Rogers BB, Shankar P, Jerris RC, Kotzbauer D, Anderson EJ, Watson JR, O'Brien LA, Uwindatwa F, McNamara K, Bost JE. 2015. Impact of a rapid respiratory panel test on patient outcomes. Arch Pathol Lab Med 139:636–641. doi:10.5858/arpa.2014-0257-OA.
    1. Lowe CF, Payne M, Puddicombe D, Mah A, Wong D, Kirkwood A, Hull MW, Leung V. 2017. Antimicrobial stewardship for hospitalized patients with viral respiratory tract infections. Am J Infect Control 45:872–875. doi:10.1016/j.ajic.2017.03.025.
    1. Rappo U, Schuetz AN, Jenkins SG, Calfee DP, Walsh TJ, Wells MT, Hollenberg JP, Glesby MJ. 2016. Impact of early detection of respiratory viruses by multiplex PCR assay on clinical outcomes in adult patients. J Clin Microbiol 54:2096–2103. doi:10.1128/JCM.00549-16.
    1. Green DA, Hitoaliaj L, Kotansky B, Campbell SM, Peaper DR. 2016. Clinical utility of on-demand multiplex respiratory pathogen testing among adult outpatients. J Clin Microbiol 54:2950–2955. doi:10.1128/JCM.01579-16.
    1. Santolaya ME, Alvarez AM, Acuna M, Aviles CL, Salgado C, Tordecilla J, Varas M, Venegas M, Villarroel M, Zubieta M, Toso A, Bataszew A, Farfan MJ, de la Maza V, Vergara A, Valenzuela R, Torres JP. 2017. Efficacy and safety of withholding antimicrobial treatment in children with cancer, fever and neutropenia, with a demonstrated viral respiratory infection: a randomized clinical trial. Clin Microbiol Infect 23:173–178. doi:10.1016/j.cmi.2016.11.001.
    1. Subramony A, Zachariah P, Krones A, Whittier S, Saiman L. 2016. Impact of multiplex polymerase chain reaction testing for respiratory pathogens on healthcare resource utilization for pediatric inpatients. J Pediatr 173:196–201. doi:10.1016/j.jpeds.2016.02.050.
    1. BioFire Diagnostics LLC. 2017. FilmArray respiratory panel 2 (RP2) instruction booklet RFIT-ASY-0129. BioFire Diagnostics LLC, Salt Lake City, UT.
    1. Song E, Kajon AE, Wang H, Salamon D, Texter K, Ramilo O, Leber A, Jaggi P. 2016. Clinical and virologic characteristics may aid distinction of acute adenovirus disease from Kawasaki disease with incidental adenovirus detection. J Pediatr 170:325–330. doi:10.1016/j.jpeds.2015.11.021.
    1. Song E, Wang H, Kajon AE, Salamon D, Dong S, Ramilo O, Leber A, Jaggi P. 2016. Diagnosis of pediatric acute adenovirus infections: is a positive PCR sufficient? Pediatr Infect Dis J 35:827–834. doi:10.1097/INF.0000000000001119.
    1. Song E, Wang H, Salamon D, Jaggi P, Leber A. 2016. Performance characteristics of FilmArray respiratory panel v1.7 for detection of adenovirus in a large cohort of pediatric nasopharyngeal samples: one test may not fit all. J Clin Microbiol 54:1479–1486. doi:10.1128/JCM.00143-16.
    1. College of American Pathologists. 2017. Microbiology checklist. CAP, Northfield, IL.
    1. BioFire Diagnostics LLC. 2015. FilmArray respiratory panel (RP) instruction booklet RFIT-ASY-0125. BioFire Diagnostics LLC, Salt Lake City, UT.
    1. Heinonen S, Jartti T, Garcia C, Oliva S, Smitherman C, Anguiano E, de Steenhuijsen Piters WA, Vuorinen T, Ruuskanen O, Dimo B, Suarez NM, Pascual V, Ramilo O, Mejias A. 2016. Rhinovirus detection in symptomatic and asymptomatic children: value of host transcriptome analysis. Am J Respir Crit Care Med 193:772–782. doi:10.1164/rccm.201504-0749OC.
    1. Jansen RR, Wieringa J, Koekkoek SM, Visser CE, Pajkrt D, Molenkamp R, de Jong MD, Schinkel J. 2011. Frequent detection of respiratory viruses without symptoms: toward defining clinically relevant cutoff values. J Clin Microbiol 49:2631–2636. doi:10.1128/JCM.02094-10.
    1. Jartti T, Jartti L, Peltola V, Waris M, Ruuskanen O. 2008. Identification of respiratory viruses in asymptomatic subjects: asymptomatic respiratory viral infections. Pediatr Infect Dis J 27:1103–1107. doi:10.1097/INF.0b013e31817e695d.
    1. Doern CD, Lacey D, Huang R, Haag C. 2013. Evaluation and implementation of FilmArray version 1.7 for improved detection of adenovirus respiratory tract infection. J Clin Microbiol 51:4036–4039. doi:10.1128/JCM.02546-13.
    1. Echavarria M, Maldonado D, Elbert G, Videla C, Rappaport R, Carballal G. 2006. Use of PCR to demonstrate presence of adenovirus species B, C, or F as well as coinfection with two adenovirus species in children with flu-like symptoms. J Clin Microbiol 44:625–627. doi:10.1128/JCM.44.2.625-627.2006.
    1. Alkhalaf MA, Guiver M, Cooper RJ. 2013. Prevalence and quantitation of adenovirus DNA from human tonsil and adenoid tissues. J Med Virol 85:1947–1954. doi:10.1002/jmv.23678.
    1. Heininger U, Burckhardt MA. 2011. Bordetella pertussis and concomitant viral respiratory tract infections are rare in children with cough illness. Pediatr Infect Dis J 30:640–644. doi:10.1097/INF.0b013e3182152d28.
    1. Piedra PA, Mansbach JM, Jewell AM, Thakar SD, Grant CC, Sullivan AF, Espinola JA, Camargo CA Jr. 2015. Bordetella pertussis is an uncommon pathogen in children hospitalized with bronchiolitis during the winter season. Pediatr Infect Dis J 34:566–570. doi:10.1097/INF.0000000000000596.
    1. Jerris RC, Williams SR, MacDonald HJ, Ingebrigtsen DR, Westblade LF, Rogers BB. 2015. Testing implications of varying targets for Bordetella pertussis: comparison of the FilmArray respiratory panel and the Focus B. pertussis PCR assay. J Clin Pathol 68:394–396. doi:10.1136/jclinpath-2014-202833.
    1. Mattoo S, Cherry JD. 2005. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 18:326–382. doi:10.1128/CMR.18.2.326-382.2005.
    1. Spicer KB, Salamon D, Cummins C, Leber A, Rodgers LE, Marcon MJ. 2014. Occurrence of 3 Bordetella species during an outbreak of cough illness in Ohio: epidemiology, clinical features, laboratory findings and antimicrobial susceptibility. Pediatr Infect Dis J 33:e162–167. doi:10.1097/INF.0000000000000262.
    1. Cherry JD, Seaton BL. 2012. Patterns of Bordetella parapertussis respiratory illnesses: 2008-2010. Clin Infect Dis 54:534–537. doi:10.1093/cid/cir860.
    1. Zouari A, Smaoui H, Brun D, Njamkepo E, Sghaier S, Zouari E, Felix R, Menif K, Ben Jaballah N, Guiso N, Kechrid A. 2012. Prevalence of Bordetella pertussis and Bordetella parapertussis infections in Tunisian hospitalized infants: results of a 4-year prospective study. Diagn Microbiol Infect Dis 72:303–317. doi:10.1016/j.diagmicrobio.2012.01.002.
    1. Kakuya F, Kinebuchi T, Okubo H, Matsuo K. 2017. Comparison of oropharyngeal and nasopharyngeal swab specimens for the detection of Mycoplasma pneumoniae in children with lower respiratory tract infection. J Pediatr 189:218–221. doi:10.1016/j.jpeds.2017.06.038.
    1. Cho MC, Kim H, An D, Lee M, Noh SA, Kim MN, Chong YP, Woo JH. 2012. Comparison of sputum and nasopharyngeal swab specimens for molecular diagnosis of Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Legionella pneumophila. Ann Lab Med 32:133–138. doi:10.3343/alm.2012.32.2.133.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅